Cargando…
Risk factors for adverse outcomes among 35 879 veterans with and without diabetes after diagnosis with COVID-19
INTRODUCTION: Risk factors and mediators of associations of diabetes with COVID-19 outcomes are unclear. RESEARCH DESIGN AND METHODS: We identified all veterans receiving Department of Veterans Affairs healthcare with ≥1 positive nasal swab for SARS-CoV-2 (28 February–31 July 2020; n=35 879). We ass...
Autores principales: | Wander, Pandora L, Lowy, Elliott, Beste, Lauren A, Tulloch-Palomino, Luis, Korpak, Anna, Peterson, Alexander C, Young, Bessie A, Boyko, Edward J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182749/ https://www.ncbi.nlm.nih.gov/pubmed/34083248 http://dx.doi.org/10.1136/bmjdrc-2021-002252 |
Ejemplares similares
-
The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection
por: Wander, Pandora L., et al.
Publicado: (2022) -
Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19
por: Wander, Pandora L., et al.
Publicado: (2021) -
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
por: Wander, Pandora L, et al.
Publicado: (2022) -
SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes
por: Wander, Pandora L., et al.
Publicado: (2023) -
Estimated excess acute-care length of stay and extra cost of testing-based versus symptom-based isolation strategies among veterans hospitalized with coronavirus disease 2019 (COVID-19) discharging to a congregate setting
por: Wu, Chenwei, et al.
Publicado: (2020)